Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and biologic effect of VG2025 in patients with advanced malignant solid tumors; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• VG2025

Snippet

Sponsor: Shanghai Virogin Biotech Co., Ltd. | Conditions: Advanced Malignant Solid Tumor | Phase 1 | Status: RECRUITING